1 July 2024
Cambridge Cognition Holdings
plc
("Cambridge Cognition" or the "Company")
Grant of
Options
Cambridge Cognition Holdings plc
(AIM: COG), which develops and markets digital solutions to assess
brain health, announces that on 28 June 2024, the Company granted
options (the "Options") over a total of 903,574 ordinary shares of
1 pence each in the capital of the Company ("Ordinary Shares")
pursuant to the Company's 2022 Long Term Incentive Plan
("LTIP").
The Options include:
1. Options over 354,421 Ordinary
Shares granted to Persons Discharging Managerial Responsibilities
("PDMRs") as follows:
|
Name
|
Role
|
Number of
Ordinary Shares over which Options Granted
|
Total
number of Ordinary Shares over which Options held following
Grant
|
Total
number of Ordinary Shares held
|
Percentage of Current Issued Share Capital Held
|
|
Matthew Stork
|
Chief Executive Officer
|
192,307
|
1,332,504
|
223,950
|
0.54%
|
|
Alex Livingstone-
Learmonth
|
Chief Commercial Officer
|
115,384
|
115,384
|
10,000
|
0.02%
|
|
Ricky Dolphin
|
Chief Technology Officer
|
46,730
|
311,589
|
120,584
|
0.29%
|
2. Options over 549,153 Ordinary
Shares granted to other employees of the Company.
The Options granted to the PDMRs are
in each case "performance share awards" that are exercisable at a
price of 1 pence per Ordinary Share from three years following the
date of award until the tenth anniversary of the date of award,
subject to continued service and to the extent to which challenging
performance conditions are achieved.
Under the terms of the
aforementioned performance conditions, one-half of each of the
Options is subject to sliding scale compound annual growth rate
targets for adjusted revenue over the three year period ending 31
December 2026, the other half of each of the Options is subject to
a sliding scale measure of relative total shareholder performance
over a three year period that commenced on the grant of the
Options.
The Options granted to other
employees of the Company (save for one more performance share
award) are exercisable at a price of 1 pence per Ordinary Share
from three years following the date of award until the tenth
anniversary of the date of award, and will vest subject to
continued service (so called 'restricted share awards').
The LTIP has scope to grant both EMI
awards and non-EMI awards and was recently adopted by the Board.
The terms of the LTIP align to best practice expectations,
including leaver terms and malus and clawback
provisions.
Following the grant of Options, the
total number of options outstanding over unissued Ordinary Shares
is 3,383,747 representing approximately 8.22% of the Company's
issued share capital.
Enquiries
|
Cambridge Cognition Holdings plc
|
|
|
Matthew Stork, Chief Executive
Officer
Stephen Symonds, Chief Financial
Officer
|
Tel: 01223 810 700
press@camcog.com
|
|
|
|
|
Panmure Liberum Limited (NOMAD
and Joint Broker)
|
Tel: 020 78862500
|
|
Freddy Crossley / Emma Earl / Mark
Rogers
|
(Corporate Advisory)
|
|
Rupert Dearden
|
(Corporate Broking)
|
|
|
|
|
Dowgate Capital Limited (Joint
Broker)
David Poutney/ James
Serjeant
|
Tel: 020 3903 7715
(Corporate Broking)
|
|
|
|
|
Hudson Sandler (Financial PR
and IR)
|
Tel: 020 7796 4133
|
|
Dan de Belder/Hattie
Dreyfus
|
|
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS
DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY
ASSOCIATED WITH THEM:
|
1.
|
Details of the person discharging managerial responsibilities
/ person closely associated
|
|
a)
|
Names
|
Matthew Stork - Chief Executive
Officer
Alex Livingstone - Learmonth - Chief
Commercial Officer
Ricky Dolphin - Chief Technology
Officer
|
|
2.
|
Reason for the Notification
|
|
a)
|
Position/status
|
See 1(a) above for positions - all
classified as PDMRs of the Company
|
|
b)
|
Initial notification/
Amendment
|
Initial Notification
|
|
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
|
a)
|
Name
|
Cambridge Cognition Holdings
plc
|
|
b)
|
LEI
|
213800SZKDIN122EPA96
|
|
|
Details of the transaction(s): section to be repeated for (i)
each type of instrument; (ii) each type of transaction; (iii) each
date; and (iv) each place where transactions have been
conducted
|
|
a)
|
Description of the Financial
instrument, type of instrument
|
In each case, the grant of Options
over Ordinary Shares on 28 June 2024
|
|
Identification code
|
GB00B8DV9647
|
|
b)
|
Nature of the transaction
|
Grant of Options over Ordinary
Shares each with an exercise price of 1 pence per Ordinary
Share
|
|
c)
|
Price(s) and volume(s)
|
Price: n/a
Volumes:
Matthew Stork - Options over 192,307
Ordinary Shares
Alex Livingstone-Learmonth - Options
over 115,384 Ordinary Shares
Ricky Dolphin - Options
over 46,730 Ordinary Shares
|
|
d)
|
Aggregated information:
· Aggregated volume
· Price
|
354,421
n/a
|
|
e)
|
Date of the transaction
|
28 June 2024
|
|
f)
|
Place of the transaction
|
Outside a trading venue
|
About
Cambridge Cognition
Cambridge Cognition is a technology
company marketing digital health products to better understand,
detect and treat conditions affecting brain health. The Company's
software products assess cognitive health in patients worldwide to
improve clinical trial outcomes, identify and stratify patients
early and improve global efficiency in pharmaceutical and
healthcare industries.
For further information visit
www.cambridgecognition.com